News
2h
Zacks.com on MSNUnitedHealth's Push Into Home Health: A New Growth Chapter?
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
UnitedHealth, Amedisys and the DOJ reached a settlement last week, clearing the way for the deal to be finalized. Amedisys ...
The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s ...
UnitedHealth Group completed its $3.3 billion purchase of Baton Rouge-based Amedisys Thursday morning, more than two years ...
Today, UnitedHealth Group (NYSE: UNH) and Amedisys tied a bow on their merger. The deal – after being beleaguered by the ...
8d
Zacks.com on MSNCan UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid ...
Thursday’s settlement is weaker than at least one antitrust expert expected based on the severity of the DOJ’s concerns. But ...
UnitedHealth Group has agreed to sell off 164 hospice and home health locations to resolve U.S. antitrust concerns over its ...
For example, after five long years the Amedisys, Inc. (NASDAQ:AMED) share price is a whole 56% lower. That's not a lot of fun for true believers. It's worthwhile assessing if the company's economics ...
Higher-for-longer interest rates have defined market leadership in recent years, but signs of softening inflation and payrolls data have shifted expectations.
In November, the DO J filed a lawsuit to challenge Amedisys' (NASDAQ: AMED) $101 a share sale to UnitedHealth (NYSE: UNH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results